SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
Follow-Up Questions
What is SCHOTT Pharma AG & Co KgaA (STTPF)'s P/E Ratio?
The P/E ratio of SCHOTT Pharma AG & Co KgaA is N/A
What is the price performance of STTPF stock?
The current price of STTPF is 0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for SCHOTT Pharma AG & Co KgaA?
SCHOTT Pharma AG & Co KgaA belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is SCHOTT Pharma AG & Co KgaA market cap?
SCHOTT Pharma AG & Co KgaA's current market cap is $0
Is SCHOTT Pharma AG & Co KgaA a buy, sell, or hold?
According to wall street analysts, 15 analysts have made analyst ratings for SCHOTT Pharma AG & Co KgaA, including 4 strong buy, 10 buy, 3 hold, 2 sell, and 4 strong sell
